Matteo Oliverio

1.2k total citations · 1 hit paper
8 papers, 451 citations indexed

About

Matteo Oliverio is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Matteo Oliverio has authored 8 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Matteo Oliverio's work include Antifungal resistance and susceptibility (4 papers), Fungal Infections and Studies (2 papers) and Virus-based gene therapy research (1 paper). Matteo Oliverio is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Fungal Infections and Studies (2 papers) and Virus-based gene therapy research (1 paper). Matteo Oliverio collaborates with scholars based in Germany, Austria and United States. Matteo Oliverio's co-authors include Rosanne Sprute, Martin Hoenigl, Danila Seidel, Ashraf S. Ibrahim, Gustavo H. Goldman, Cristina Cunha, Agostinho Carvalho, Jan‐Wilhelm Kornfeld, Juergen Prattes and Björn Rath and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecular Aspects of Medicine.

In The Last Decade

Matteo Oliverio

8 papers receiving 436 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COVID-19-associated fungal infections

2022 269 citations Martin Hoenigl, Danila Seidel et al. Nature Microbiology profile →

Peers

Countries citing papers authored by Matteo Oliverio

Since Specialization

Citations

This map shows the geographic impact of Matteo Oliverio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Oliverio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Oliverio more than expected).

Fields of papers citing papers by Matteo Oliverio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Oliverio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Oliverio. The network helps show where Matteo Oliverio may publish in the future.

Co-authorship network of co-authors of Matteo Oliverio

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Oliverio. A scholar is included among the top collaborators of Matteo Oliverio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Oliverio. Matteo Oliverio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Social determinants of health as drivers of fungal disease 2023 ·EClinicalMedicine ·Jeffrey D. Jenks, Juergen Prattes, Sebastian Wurster, Rosanne Sprute, Danila Seidel, Matteo Oliverio, Matthias Egger, Carlos del Rı́o, Hatim Sati, Oliver A. Cornely, George R. Thompson, Dimitrios P. Kontoyiannis, Martin Hoenigl	30
2	Antifungal prophylaxis and pre-emptive therapy: When and how? 2023 ·Molecular Aspects of Medicine ·Rosanne Sprute, (unknown), Dionysios Neofytos, Matteo Oliverio, Juergen Prattes, (unknown), Oliver A. Cornely, Jannik Stemler	18
3	COVID-19-associated fungal infections breakdown → 2022 ·Nature Microbiology ·Martin Hoenigl, Danila Seidel, Rosanne Sprute, Cristina Cunha, Matteo Oliverio, Gustavo H. Goldman, Ashraf S. Ibrahim, Agostinho Carvalho	269
4	Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action 2022 ·Expert Opinion on Investigational Drugs ·Martin Hoenigl, Rosanne Sprute, Amir Arastehfar, John R. Perfect, Cornelia Lass‐Flörl, Romuald Bellmann, Juergen Prattes, George R. Thompson, Nathan P. Wiederhold, (unknown), Birgit Willinger, Maiken Cavling Arendrup, Philipp Koehler, Matteo Oliverio, Matthias Egger, Ilan S. Schwartz, Oliver A. Cornely, Peter G. Pappas, Robert Krause	29
5	Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations 2021 ·Scientific Reports ·(unknown), (unknown), (unknown), Matteo Oliverio, (unknown), Jan‐Wilhelm Kornfeld, Wacharee Harnying, Kurt Pfannkuche, Jürgen Hescheler, Albrecht Berkessel, Tomo Šarić	4
6	Senescence-Associated Metabolomic Phenotype in Primary and iPSC-Derived Mesenchymal Stromal Cells 2020 ·Stem Cell Reports ·Eduardo Fernández‐Rebollo, Julia Franzen, Roman Goetzke, (unknown), Alina Ostrowska, Matteo Oliverio, (unknown), Björn Rath, Jan‐Wilhelm Kornfeld, Wolfgang Wagner	63
7	Chronic Replication Problems Impact Cell Morphology and Adhesion of DNA Ligase I Defective Cells 2015 ·PLoS ONE ·Paolo Cremaschi, Matteo Oliverio, (unknown), Silvia Bione, Roberta Carriero, (unknown), Andrea Palamidessi, Giorgio Scita, Giuseppe Biamonti, Alessandra Montecucco	5
8	Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation 2015 ·Stem Cell Research & Therapy ·A Brodarac, Tomo Šarić, Barbara Oberwallner, Shokoufeh Mahmoodzadeh, Klaus Neef, Julie A. Albrecht, (unknown), Matteo Oliverio, Filomain Nguemo, Yeong‐Hoon Choi, Wolfram F. Neiss, Ingo Morano, Jürgen Hescheler, Christof Stamm	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact